In this issue:
Biologics vs oral treatments for plaque psoriasis
Major cardiovascular events with biologics in psoriasis
Guselkumab for pustulotic arthro-osteitis
Dupilumab in adolescents with uncontrolled moderate-to-severe AD
Dupilumab regimens for AD
Dupilumab for chronic nodular prurigo
Dupilumab for bullous pemphigoid
Bevacizumab vs triamcinolone acetonide in infantile haemangioma
Omalizumab for chronic spontaneous urticaria
TNF-α inhibitors for SJS-TEN
Please login below to download this issue (PDF)